纯自体脂肪移植:可行性、满意度与生活质量
该单中心回顾性研究纳入118例2015年4月至2020年11月间计划行纯自体脂肪移植乳房再造的患者,成功率为72.88%(86例),唯一客观化的失败风险因素为放疗(OR=2.90);85%患者认为结果符合预期,82.93%自评生活质量好或很好。作者认为该技术可重复性好、严重并发症罕见,但可能应保留给有动机且乳房较小或同意对侧乳房缩小术的患者。
要点
- 纯自体脂肪移植乳房再造成功率为72.88%(86/118例)。
- 唯一客观化的失败风险因素为放疗(OR=2.90)。
- 85%患者认为结果符合预期,82.93%自评生活质量好或很好。
核心结论
- 作者认为纯自体脂肪移植技术描述充分、易于重复,严重并发症罕见,可实现比游离或带蒂皮瓣创伤更小的自体再造。
- 作者认为此类再造可能应保留给有动机且乳房较小或同意对侧乳房缩小术的患者。
研究设计与样本
- 单中心回顾性研究,纳入118例2015年4月至2020年11月间计划行纯自体脂肪移植乳房再造的患者。
主要发现
- 成功率为72.88%(86例)。
- 唯一客观化的失败风险因素为放疗(OR=2.90)。
- 85%患者认为结果符合预期。
- 82.93%患者自评生活质量为好或很好。
临床怎么用
- 作者认为纯自体脂肪移植乳房再造可能应保留给有动机且乳房较小或同意对侧乳房缩小术的患者。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The main objective of this study was to assess the feasibility of breast reconstruction by exclusive autologous fat grafting (AFG). The secondary objectives were to identify predictive factors for technique failure and to assess the satisfaction and quality of life of patients who have benefited from exclusive AFG breast reconstruction using satisfaction and WHOQOL-BREF surveys. METHOD: We carried out a monocentric retrospective study. We included 118 patients who achieved breast reconstruction that was initially planned as exclusive AFG reconstruction, between April 2015 and November 2020. RESULTS: The success rate was 72.88% (86 patients). The only risk factor for failure we objectified was irradiation (OR=2.90). A total of 85 percent of patients felt that the result met their expectations. However, 82.93% rated their quality of life as good or very good. CONCLUSION: The AFG technique is well described, easily reproducible, and serious complications are rare. It allows for a less invasive autologous reconstruction than free or pedicle flaps. This type of reconstruction should probably be reserved for motivated patients with a small breast size or agreeing to a contralateral breast reduction procedure.
引用
- Lemaitre J, Boiffard F, Dravet F, et al. Exclusive autologous fat grafting: Feasibility, satisfaction, and quality of life. J Plast Reconstr Aesthet Surg. 2022. PMID: 36089475. doi:10.1016/j.bjps.2022.06.055
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。